Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue.

Por Ziesche, R, Petkov, V, Williams, J, Zakeri, S M, Mosgöller, W, Knöfler, M, Block, L H
Publicado em 1996

Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD

Por Vonbank, K, Ziesche, R, Higenbottam, T, Stiebellehner, L, Petkov, V, Schenk, P, Germann, P, Block, L
Publicado em 2003

Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension

Por Ziesche, R, Petkov, V, Wittmann, K, Kopatschka, J, Stiebellehner, L, Schenk, P, Germann, P, Roder, G, Ullrich, R, Block, L
Publicado em 2000

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment

Por Petkov, V, Ziesche, R, Mosgoeller, W, Schenk, P, Vonbank, K, Stiebellehner, L, Raderer, M, Brunner, C., Kneussl, M, Block, L
Publicado em 2001